R. Barletta

发表

Pathogenesis, Molecular Genetics, and Genomics of Mycobacterium avium subsp. paratuberculosis, the Etiologic Agent of Johne’s Disease

D. Zinniel, J. Stabel, Y. Gröhn, 2017, Front. Vet. Sci..

Whole genomic sequence analysis of Bacillus infantis: defining the genetic blueprint of strain NRRL B-14911, an emerging cardiopathogenic microbe

Timothy P. L. Smith, C. Guda, E. Moriyama, 2016, BMC Genomics.

Immunogenicity and Reactivity of Novel Mycobacterium avium subsp. paratuberculosis PPE MAP1152 and Conserved MAP1156 Proteins with Sera from Experimentally and Naturally Infected Animals

D. S. McVey, David R. Smith, C. Czuprynski, 2010, Clinical and Vaccine Immunology.

Development of a Firefly Luciferase-Based Assay for Determining Antimicrobial Susceptibility of Mycobacterium aviumsubsp. paratuberculosis

N. B. Harris, R. Barletta, Stephanie L. Williams, 1999, Journal of Clinical Microbiology.

Predicting the in vivo mechanism of action for drug leads using NMR metabolomics.

R. Powers, R. Barletta, Steven M. Halouska, 2012, ACS chemical biology.

Role of Mycobacterium tuberculosis PE and PPE Proteins in Pathogen-Host Interactions

D. Zinniel, Govardhan Rathnaiah, R. Barletta, 2019, Tuberculosis Host-Pathogen Interactions.

Peyer's Patch-Deficient Mice Demonstrate That Mycobacterium avium subsp. paratuberculosis Translocates across the Mucosal Barrier via both M Cells and Enterocytes but Has Inefficient Dissemination

L. Bermudez, M. Petrofsky, R. Barletta, 2010, Infection and Immunity.

A rational framework for evaluating the next generation of vaccines against Mycobacterium avium subspecies paratuberculosis

S. Sreevatsan, P. Coussens, V. Kapur, 2014, Front. Cell. Infect. Microbiol..

D-ALANINE RACEMASE MUTANTS OF MYCOBACTERIA AND USES THEREFORE: U.S. Patent No. US 6,929,799 B2

R. Barletta, Ofelia Barletta-Chacon, 2005 .

United States Patent: D-ALANINE RACEMASE MUTANTS OF MYCOBACTERIA AND USES THEREFORE

R. Barletta, Ofelia Barletta-Chacon, 2005 .

ATP release by infected bovine monocytes increases the intracellular survival of Mycobacterium avium subsp. paratuberculosis.

C. Czuprynski, R. Barletta, Seng-Ryong Woo, 2009, Comparative immunology, microbiology and infectious diseases.

The pathogenicity of Aspergillus fumigatus, drug resistance, and nanoparticle delivery.

D. Zinniel, R. Barletta, David A Szalewski, 2018, Canadian journal of microbiology.

Pathogenicity of an EnterotoxigenicEscherichia coli Hemolysin (hlyA) Mutant in Gnotobiotic Piglets

R. Moxley, D. Francis, R. Welch, 1998, Infection and Immunity.

Plasmid transformation and expression of the firefly luciferase in Microbacterium testaceum type and endophytic colonizing field strains.

P. Blum, D. Zinniel, A. Vidaver, 2008, Canadian journal of microbiology.

Genetic Resistance of Mice to Mycobacterium paratuberculosis Is Influenced by Slc11a1 at the Early but Not at the Late Stage of Infection

D. Zinniel, R. Barletta, K. Huygen, 2008, Infection and Immunity.

Revisiting Protocols for the NMR Analysis of Bacterial Metabolomes.

R. Powers, Bo Zhang, G. Somerville, 2013, Journal of integrated OMICS.

ESCHERICHIA COLI STRAINS PRODUCING STREPTOCOCCUS MUTANS PROTEINS RESPONSIBLE FOR COLONIZATION AND VIRULENCE *

R. Curtiss, R. Barletta, J. Robeson, 1983, Annals of the New York Academy of Sciences.

Life and death in bovine monocytes: the fate of Mycobacterium avium subsp. paratuberculosis.

R. Albrecht, C. Czuprynski, R. Barletta, 2007, Microbial pathogenesis.

Generation and screening of a comprehensive Mycobacterium avium subsp. paratuberculosis transposon mutant bank

S. Sreevatsan, C. Czuprynski, N. B. Harris, 2014, Front. Cell. Infect. Microbiol..

Demonstration of Allelic Exchange in the Slow-Growing Bacterium Mycobacterium avium subsp. paratuberculosis, and Generation of Mutants with Deletions at the pknG, relA, and lsr2 Loci

Jongsam Ahn, M. Hamilton, K. Park, 2008, Applied and Environmental Microbiology.

Evaluation of eight live attenuated vaccine candidates for protection against challenge with virulent Mycobacterium avium subspecies paratuberculosis in mice

V. Kapur, J. Everman, L. Bermudez, 2014, Front. Cell. Infect. Microbiol..

Evaluation of novel oral vaccine candidates and validation of a caprine model of Johne's disease

V. Kapur, Ling-ling Li, S. Turnquist, 2014, Front. Cell. Infect. Microbiol..

Expression of a Streptococcus mutans glucosyltransferase gene in Escherichia coli

R. Curtiss, R. Barletta, J. Robeson, 1983, Journal of bacteriology.

Characterization of a Mycobacterium smegmatis Mutant That is Simultaneously Resistant to D-Cycloserine and Vancomycin " , AntimicrobialAgents and Chemotherapy

R. Barletta, 2017 .

Metabolomics analysis identifies d-Alanine-d-Alanine ligase as the primary lethal target of d-Cycloserine in mycobacteria.

R. Powers, D. Zinniel, Darrell D. Marshall, 2014, Journal of proteome research.

Molecular analysis of the Mycobacterium tuberculosis lux-like mel2 operon.

D. Zinniel, J. Cirillo, H. Janagama, 2013, Tuberculosis.

Transposon Mutagenesis in Mycobacterium avium Subspecies Paratuberculosis.

D. Zinniel, J. Bannantine, R. Barletta, 2019, Methods in molecular biology.

Characterization of the Mycobacterium avium subsp. paratuberculosis laminin-binding/histone-like protein (Lbp/Hlp) which reacts with sera from patients with Crohn's disease.

C. Locht, J. Hugot, H. Drobecq, 2011, Microbes and infection.

Immune response of pigs inoculated with Mycobacterium bovis BCG expressing a truncated form of GP5 and M protein of porcine reproductive and respiratory syndrome virus.

F. Osorio, E. Nelson, F. Zuckermann, 2004, Vaccine.

Endophytic Colonizing Bacteria from Isolation and Characterization of

N. B. Harris, D. Zinniel, C. Ishimaru, 2014 .

Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens.

D. Sosnowska, L. Bermudez, J. McGarvey, 2002, The Journal of infectious diseases.

Isolation and Characterization of Endophytic Colonizing Bacteria from Agronomic Crops and Prairie Plants

N. B. Harris, D. Zinniel, C. Ishimaru, 2002, Applied and Environmental Microbiology.

Draft 1 The Pathogenicity of Aspergillus fumigatus , Drug Resistance and 1 Nanoparticle Delivery 2 3

D. Zinniel, R. Barletta, David A Szalewski, 2018 .

Antigenicity of Mycobacterium paratuberculosis superoxide dismutase in mice.

A. Hovav, H. Bercovier, R. Barletta, 2002, FEMS immunology and medical microbiology.

Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis.

L. Bermudez, R. Barletta, Ofelia Chacon, 2004, Annual review of microbiology.

Mycobacterium avium subsp. paratuberculosisin Veterinary Medicine

N. B. Harris, R. Barletta, N. Beth, 2001, Clinical Microbiology Reviews.

Application of the genome sequence to address concerns that Mycobacterium avium subspecies paratuberculosis might be a foodborne pathogen.

V. Kapur, J. Stabel, M. Paustian, 2004, Foodborne pathogens and disease.

Impairment of melibiose utilization in Streptococcus mutans serotype c gtfA mutants

R. Curtiss, R. Barletta, 1989, Infection and immunity.

Impairment ofMelibiose Utilization inStreptococcus mutans Serotype cgtfAMutants

R. Barletta, 1989 .

Sample preparation of Mycobacterium tuberculosis extracts for nuclear magnetic resonance metabolomic studies.

R. Powers, D. Zinniel, R. Barletta, 2012, Journal of visualized experiments : JoVE.

Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis

V. Kapur, N. B. Harris, J. Wellehan, 1997, Journal of bacteriology.

Preparation of D-cycloserine and 13C-labeled D-cycloserine

R. Barletta, J. M. Takacs, Nathan C. Thacker, 2012 .

Molecular cloning, sequencing, and characterization of bovine transporter associated with antigen processing 2 (BoTAP2)

S. Srikumaran, R. Barletta, A. Ambagala, 2002, Immunogenetics.

The immunogenicity of Mycobacterium paratuberculosis 85B antigen

A. Hovav, H. Bercovier, R. Barletta, 2002, Medical Microbiology and Immunology.

Identification of Mycobacterium paratuberculosis gene expression signals.

C. Thoen, R. Barletta, R. Andrews, 1997, Microbiology.

Harnessing Mycobacterium bovis BCG Trained Immunity to Control Human and Bovine Babesiosis

C. Suárez, B. Cooke, O. Dellagostin, 2022, Vaccines.

Chapter 7. Mycobacterium

C. Thoen, R. Barletta, I. Olsen, 2010 .

Monoclonal vs. heterogeneous anti‐H‐8 antibodies in the analysis of the anti‐phosphorylcholine response in BALB/c mice

J. Kearney, R. Barletta, J. Quintáns, 1981, European journal of immunology.

Multi-omics Investigation into the Mechanism of Action of an Anti-tubercular Fatty Acid Analogue.

R. Powers, D. Zinniel, A. Maroli, 2022, Journal of the American Chemical Society.

Development of Luminescent Mycobacterium avium subsp. paratuberculosis for Rapid Screening of Vaccine Candidates in Mice

D. Zinniel, R. Barletta, K. Huygen, 2006, Infection and Immunity.

Roles of Mycobacterium smegmatisd-Alanine:d-Alanine Ligase and d-Alanine Racemase in the Mechanisms of Action of and Resistance to the Peptidoglycan Inhibitor d-Cycloserine

R. Barletta, Zhengyu Feng, 2003, Antimicrobial Agents and Chemotherapy.

Deciphering the mechanism of action of antitubercular compounds with metabolomics

R. Powers, R. Barletta, P. Dussault, 2021, Computational and structural biotechnology journal.

Novel Amphiphilic Cyclobutene and Cyclobutane cis-C18 Fatty Acid Derivatives Inhibit Mycobacterium avium subsp. paratuberculosis Growth

R. Powers, D. Zinniel, Darrell D. Marshall, 2019, Veterinary sciences.

Development of Cyclobutene‐ and Cyclobutane‐Functionalized Fatty Acids with Inhibitory Activity against Mycobacterium tuberculosis

R. Powers, Ji-Young Lee, D. Zinniel, 2014, ChemMedChem.

Use of NMR metabolomics to analyze the targets of D-cycloserine in mycobacteria: role of D-alanine racemase.

R. Powers, D. Zinniel, R. Barletta, 2007, Journal of proteome research.

Elucidating the Regulon of a Fur-like Protein in Mycobacterium avium subsp. paratuberculosis (MAP)

S. Sreevatsan, J. Bannantine, R. Barletta, 2020, Frontiers in Microbiology.

Bovine monocytes and a macrophage cell line differ in their ability to phagocytose and support the intracellular survival of Mycobacterium avium subsp. paratuberculosis.

C. Czuprynski, R. Barletta, Seng-Ryong Woo, 2006, Veterinary immunology and immunopathology.

Mycobacterium smegmatisl-Alanine Dehydrogenase (Ald) Is Required for Proficient Utilization of Alanine as a Sole Nitrogen Source and Sustained Anaerobic Growth

G. Sarath, R. Barletta, Zhengyu Feng, 2002, Journal of bacteriology.

Impairment of D-alanine biosynthesis in Mycobacterium smegmatis determines decreased intracellular survival in human macrophages.

L. Bermudez, D. Zinniel, R. Barletta, 2009, Microbiology.

Construction and immunogenicity of recombinant Mycobacterium bovis BCG expressing GP5 and M protein of porcine reproductive respiratory syndrome virus.

F. Osorio, E. Nelson, A. Doster, 2002, Vaccine.

Structure of the Mycobacterium tuberculosis d-Alanine:d-Alanine Ligase, a Target of the Antituberculosis Drug d-Cycloserine

James C. Sacchettini, J. Sacchettini, J. Bruning, 2010, Antimicrobial Agents and Chemotherapy.

A Ferritin Nanoparticle-Based Zika Virus Vaccine Candidate Induces Robust Humoral and Cellular Immune Responses and Protects Mice from Lethal Virus Challenge

Bikash R. Sahoo, G. Borgstahl, Aryamav Pattnaik, 2023, Vaccines.

Assessment of Metabolic Changes in Mycobacterium smegmatis Wild-Type and alr Mutant Strains: Evidence of a New Pathway of d-Alanine Biosynthesis.

R. Powers, D. Zinniel, Darrell D. Marshall, 2017, Journal of proteome research.

Analysis of the virulence of Streptococcus mutans serotype c gtfA mutants in the rat model system

S. Michalek, R. Curtiss, R. Barletta, 1988, Infection and immunity.

Extracellular ATP Is Cytotoxic to Mononuclear Phagocytes but Does Not Induce Killing of Intracellular Mycobacterium avium subsp. paratuberculosis

C. Czuprynski, R. Barletta, Seng-Ryong Woo, 2007, Clinical and Vaccine Immunology.

Mycobacterium smegmatis d-Alanine Racemase Mutants Are Not Dependent on d-Alanine for Growth

N. B. Harris, R. Barletta, L. G. Adams, 2002, Antimicrobial Agents and Chemotherapy.

Development of luminescent M. avium subsp. paratuberculosis for rapid screening of vaccine candidates in mice

D. Zinniel, R. Barletta, K. Huygen, 2005 .

Pathogenesis of Mycobacterium Bovis

C. Thoen, R. Barletta, Charles O. Thoen, 2006 .

Mycobacterium avium subsp. paratuberculosis Candidate Vaccine Strains Are Pro-apoptotic in RAW 264.7 Murine Macrophages

D. Zinniel, J. Stabel, J. Bannantine, 2023, Vaccines.

Chapter 7. Mycobacterium

C. Thoen, R. Barletta, I. Olsen, 2010 .

Pathogenesis of tuberculosis caused by Mycobacterium bovis

C. Thoen, R. Barletta, 2014 .

Impairment of D-alanine biosynthesis in Mycobacterium smegmatis determines decreased intracellular survival in human macrophages.

L. Bermudez, D. Zinniel, R. Barletta, 2009, Microbiology.

Analysis of Mycobacterium avium subsp. paratuberculosis Mutant Libraries Reveals Loci-dependent Transposition Biases and Strategies to Novel Mutant Discovery.

D. Zinniel, D. Bayles, J. Bannantine, 2016, Microbiology.

Analysis of Analysis of Mycobacterium avium Mycobacterium avium paratuberculosis paratuberculosis mutant libraries reveals loci-dependent transposition biases and mutant libraries reveals loci-dependent transposition biases and strategies for novel mutant discovery strategies for novel mutant discov

D. Zinniel, J. Stabel, D. Bayles, 2021 .